United States Army Medical Materiel Development Activity - Project Management Offices

Project Management Offices

USAMMDA project managers address critical readiness issues identified in user requirement documents to meet cost, schedule and performance objectives. Tailored procurement, rapid prototyping and a variety of cooperative and contractual arrangements with academia and industry are among the most current acquisition procedures used. Project Management Offices (PMO) include:

• Medical Support Systems (MSS) PMO advances development of medical products used to sustain and support the Warfighter. Product managers analyze functional requirements, conduct market investigations, and plan for all acquisition program phases. MSSPMO designs, develops, and tests field medical equipment and specializes in developing innovative technology as well as adapting commercial off-the-shelf (COTS) systems. The Medical Prototype Development Laboratory is a small team of engineering technicians who rapidly design and build prototype medical devices, and harden COTS products for use in a field environment.

• Pharmaceutical Systems PMO centrally manages the development and acquisition of pharmaceutical and biological products (drugs, vaccines, diagnostics, protective and therapeutic modalities for use against infectious diseases and similar products for combat casualty care). Product Managers work with USAMRMC laboratories, academia, and industry partners (both domestic and foreign) to identify, develop, license, and field products to remedy deficiencies identified by the Army Medical Department Combat Developer.

• Armed Forces Institute of Regenerative Medicine (AFIRM) PMO is a multi-Institutional, interdisciplinary network working to develop advanced treatment options for our severely wounded service members. AFIRM is managed and funded through the USAMRMC; with additional funding from the U.S. Navy, Office of Naval Research; the U.S. Air Force, OTSG; the National Institutes of Health; the Veterans Administration; and local public and private matching funding.

• Hyperbaric Oxygen (HBO2) Treatment For Mild Traumatic Brain Injury (mTBI) is the administration of oxygen in a chamber at greater than sea-level atmospheric pressure in which oxygen becomes increasingly dissolved in the blood, resulting in greater than normal every day oxygen tension in cells and tissues in the body. There is some compelling anecdotal evidence to suggest this may be beneficial in the treatment of acute and chronic symptoms linked to traumatic brain injury. Stronger evidence must be obtained prior to determine if HBO2 should be used as a treatment for TBI.

• Neurotrauma and Psychological Health (NPH) PMO was formed in May 2011 to support advanced development of materiel and select nonmateriel (Medical Knowledge) products to protect, sustain and care for Warriors with TBI and psychological health issues including Posttraumatic Stress Disorder. Additionally NPH provides advanced development assistance to USAMRMC Military Operational Medicine and Combat Casualty Care Research Programs and associated Joint Program Committees.